Omalizumab - Wikipedia, the free encyclopedia
Omalizumab (trade name Xolair, Genentech / Novartis) is a humanized antibody drug approved for patients with moderate-to-severe or severe allergic asthma, which is caused by ...
Genentech - Wikipedia, the free encyclopedia
2003 - Xolair (omalizumab) - Subcutaneous injection for moderate to severe persistent asthma. 2003 - Raptiva (efalizumab) - Antibody designed to block the activation and reactivation ...
EXPECT Registry
Now Enrolling. An observational Pregnancy Registry is under way to evaluate pregnancy outcomes in women who have received XOLAIR prior to conception or at any time during pregnancy ...
Xolair - Drugs & Treatments - Revolution Health
What is Xolair (Omalizumab)? Omalizumab is an antibody that helps decrease allergic responses in the body. Omalizumab is used to treat moderate to severe asthma that is caused by ...
Xolair - definition of Xolair in the Medical dictionary - by the Free ...
Xo·lair (z lâr) A trademark for the drug omalizumab. Xolair, a trademark for omalizumab. omalizumab. Xolair. Pharmacologic class: Recombinant DNA-derived immunoglobulin G ...
Omalizumab - Wikipedia, the free encyclopedia
Omalizumab (trade name Xolair, Genentech / Novartis) is a humanized antibody drug approved for patients with moderate-to-severe or severe allergic asthma, which is caused by ...
Xolair Warning - Defective Drug Information
The makers of the asthma drug Xolair were ordered in February 2007 to add a black box warning to the label, alerting doctors and patients of the serious side effects associated ...
Xolair Gets 'Black Box' Warning
The asthma drug Xolair has a new ... July 3, 2007 -- The asthma drug Xolair has a new "black box" warning about severe, potentially life-threatening allergic reaction (anaphylaxis ...
Xolair Anaphylaxis Allergic Reaction Injury Lawyer
If you or a loved one have been administered Xolair and experienced anaphylaxis, a life threatening allergic reaction you may be entitled to compensation. Please fill out the form ...
XOLAIR® Omalizumab
Xolair ® (Omalizumab) for Subcutaneous Use—Genentech, Inc. July 2008 XOLAIR ® Omalizumab For Subcutaneous Use WARNING Anaphylaxis, presenting as bronchospasm, hypotension ...
Xolair -- Xolair Safety and Side Effects - Omalizumab
Xolair is a relatively new injectable medication used to treat moderate to severe asthma. It is the only medication that acts to block allergic antibody, or IgE, which is the ...
Xolair
Xolair is a prescription drug that is approved to prevent allergic asthma. This eMedTV page explains how the Xolair injection works to prevent asthma attacks due to certain ...
Xolair, New York Dangerous Drug Lawyer, Class Action Attorneys, Anti ...
Xolair, New York Dangerous Drug Lawyer, Class Action Attorneys, Anti-Asthma Medication, Allergic Reaction, Wrongful Death Claims, Side Effect, Anaphylaxis, Blood Pressure Drop ...
